These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33375207)

  • 21. N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins.
    Higel F; Seidl A; Sörgel F; Friess W
    Eur J Pharm Biopharm; 2016 Mar; 100():94-100. PubMed ID: 26775146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High affinity human Fc specific monoclonal antibodies for capture kinetic analyses of antibody-antigen interactions.
    Kamat V; Boutot C; Rafique A; Granados C; Wang J; Badithe A; Torres M; Chatterjee I; Olsen O; Olson W; Huang T
    Anal Biochem; 2022 Mar; 640():114455. PubMed ID: 34788604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of NMR and Chemometric Analyses to Better Understand the Quality Attributes in pH and Thermally Degraded Monoclonal Antibodies.
    Beaumont VA; Liu L; Shi H; Rouse JC; Kim HY
    Pharm Res; 2023 Oct; 40(10):2457-2467. PubMed ID: 37798537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis.
    Pepinsky RB; Silvian L; Berkowitz SA; Farrington G; Lugovskoy A; Walus L; Eldredge J; Capili A; Mi S; Graff C; Garber E
    Protein Sci; 2010 May; 19(5):954-66. PubMed ID: 20198683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches.
    Li M; Beaumont VA; Akbar S; Duncan H; Creasy A; Wang W; Sackett K; Marzilli L; Rouse JC; Kim HY
    MAbs; 2024; 16(1):2292688. PubMed ID: 38117548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies.
    Kayser V; Chennamsetty N; Voynov V; Forrer K; Helk B; Trout BL
    Biotechnol J; 2011 Jan; 6(1):38-44. PubMed ID: 20949542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Structural Role of Antibody N-Glycosylation in Receptor Interactions.
    Subedi GP; Barb AW
    Structure; 2015 Sep; 23(9):1573-1583. PubMed ID: 26211613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into intra- and intermolecular interactions of immunoglobulins: crystal structure of mouse IgG2b-Fc at 2.1-A resolution.
    Kolenko P; Dohnálek J; Dusková J; Skálová T; Collard R; Hasek J
    Immunology; 2009 Mar; 126(3):378-85. PubMed ID: 18783468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.
    Wada R; Matsui M; Kawasaki N
    MAbs; 2019; 11(2):350-372. PubMed ID: 30466347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals.
    Wen J; Batabyal D; Knutson N; Lord H; Wikström M
    J Pharm Sci; 2020 Jan; 109(1):247-253. PubMed ID: 31669605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycoform-resolved FcɣRIIIa affinity chromatography-mass spectrometry.
    Lippold S; Nicolardi S; Domínguez-Vega E; Heidenreich AK; Vidarsson G; Reusch D; Haberger M; Wuhrer M; Falck D
    MAbs; 2019 Oct; 11(7):1191-1196. PubMed ID: 31276431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosylation of IgG-Fc: a molecular perspective.
    Kiyoshi M; Tsumoto K; Ishii-Watabe A; Caaveiro JMM
    Int Immunol; 2017 Jul; 29(7):311-317. PubMed ID: 28655198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restricted processing of CD16a/Fc γ receptor IIIa
    Patel KR; Roberts JT; Subedi GP; Barb AW
    J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J; Zheng YZ; James DC
    Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.
    Goetze AM; Liu YD; Zhang Z; Shah B; Lee E; Bondarenko PV; Flynn GC
    Glycobiology; 2011 Jul; 21(7):949-59. PubMed ID: 21421994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of deglycosylated human IgG4-Fc.
    Davies AM; Jefferis R; Sutton BJ
    Mol Immunol; 2014 Nov; 62(1):46-53. PubMed ID: 24956411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multivariate Analysis of Two-Dimensional
    Arbogast LW; Delaglio F; Schiel JE; Marino JP
    Anal Chem; 2017 Nov; 89(21):11839-11845. PubMed ID: 28937210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platform development for expression and purification of stable isotope labeled monoclonal antibodies in Escherichia coli.
    Reddy PT; Brinson RG; Hoopes JT; McClung C; Ke N; Kashi L; Berkmen M; Kelman Z
    MAbs; 2018 Oct; 10(7):992-1002. PubMed ID: 30060704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.
    Singh SM; Bandi S; Jones DNM; Mallela KMG
    J Pharm Sci; 2017 Dec; 106(12):3486-3498. PubMed ID: 28843351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sculpting therapeutic monoclonal antibody N-glycans using endoglycosidases.
    Trastoy B; Du JJ; García-Alija M; Li C; Klontz EH; Wang LX; Sundberg EJ; Guerin ME
    Curr Opin Struct Biol; 2022 Feb; 72():248-259. PubMed ID: 34998123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.